UBS AM’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $198K | Hold |
|
|||||
|
2021
Q4 | $266K | Hold |
|
|||||
|
2021
Q3 | $438K | Sell |
|
|||||
|
2021
Q2 | $739K | Buy |
|
|||||
|
2021
Q1 | $542K | Sell |
|
|||||
|
2020
Q4 | $385K | Buy |
|
|||||
|
2020
Q3 | $455K | Sell |
|
|||||
|
2020
Q2 | $538K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $221K | Buy |
|
|||||
|
2019
Q2 | $581K | Buy |
|
|||||
|
2019
Q1 | $856K | Buy |
|
|||||
|
2018
Q4 | $339K | Sell |
|
|||||
|
2018
Q3 | $3.15M | Buy |
|
|||||
|
2018
Q2 | $4.78M | Sell |
|
|||||
|
2018
Q1 | $22.2M | Sell |
|
|||||
|
2017
Q4 | $37.5M | Buy |
|
|||||
|
2017
Q3 | $30.8M | Buy |
|
|||||
|
2017
Q2 | $26.6M | Buy |
|
|||||
|
2017
Q1 | $17.3M | Buy |
|
|||||
|
2016
Q4 | $11.3M | Sell |
|
|||||
|
2016
Q3 | $9.45M | Buy |
|
|||||
|
2016
Q2 | $169K | Hold |
|
|||||
|
2016
Q1 | $236K | Sell |
|
|||||
|
2015
Q4 | $472K | Sell |
|
|||||
|
2015
Q3 | $1.87M | Buy |
|
|||||
|
2015
Q2 | $1.02M | Buy |
|
|||||
|
2015
Q1 | $638K | Buy |
|
|||||
|
2014
Q4 | $459K | Buy |
|
|||||
|
2014
Q3 | $340K | Hold |
|
|||||
|
2014
Q2 | $311K | Hold |
|
|||||
|
2014
Q1 | $520K | Buy |
|
|||||
|
2013
Q4 | $428K | Buy |
|
|||||
|
2013
Q3 | $286K | Buy |
|